申请人:UTI LIMITED PARTNERSHIP
公开号:US20190262353A1
公开(公告)日:2019-08-29
In one aspect, there is provided a method of treating, prophylaxis, or amelioration of a neurological disease by administering to a subject in need thereof one or more compounds described herein. In a specific example, the neurological disease is multiple sclerosis (also referred to as “MS”).